Schedule 13G ownership disclosure
Actinium Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00507W107
Event date: 2020-04-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 20,095,255
- Percent of class
- 7.2900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-20-000091
- Form type
- SC 13G
- Filer
- Actinium Pharmaceuticals, Inc.
- CIK
- CIK 1388320
- Filed
- May 01, 2020
- Reporting period
- Apr 22, 2020
- Description
- Schedule 13G beneficial ownership